Genomic and immune characteristics of <i>HER2</i>‐mutated non‐small‐cell lung cancer and response to immune checkpoint inhibitor‐based therapyHai‐Yan Tu, Yi‐Long Wu, Xiaotian Zhao et al.|Molecular Oncology|2023Cited by 9